Impact of galectins in resistance to anticancer therapies

P Navarro, N Martínez-Bosch, AG Blidner… - Clinical Cancer …, 2020 - AACR
Galectins are an endogenous family of β-galactoside-binding proteins that play complex and
multifaceted roles at various stages of cancer progression, including modulation of tumor …

[HTML][HTML] Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer

VS Junior, GM de Mendonca Fernandes… - Cytokine, 2020 - Elsevier
The tropomyosin-related kinase B (TrkB) receptor is a member of the neurotrophic tyrosine
kinase receptors family and, together with the brain-derived neurotrophic factor (BDNF) …

Ionizing radiation-induced extracellular vesicle release promotes AKT-associated survival response in SH-SY5Y neuroblastoma cells

F Tortolici, S Vumbaca, B Incocciati, R Dayal… - Cells, 2021 - mdpi.com
Radiation therapy is one of the most effective methods of tumor eradication; however, in
some forms of neuroblastoma, radiation can increase the risk of secondary neoplasms, due …

Galectins in cancer and translational medicine: From bench to bedside

A Bartolazzi - International Journal of Molecular Sciences, 2018 - mdpi.com
Galectins (also worded S-type lectins) are an evolutionarily conserved family of
carbohydratebinding proteins characterized by the presence of β-galactoside-binding sites …

Linc01105 Acts as an Oncogene in the Development of Neuroblastoma Corrigendum in/10.3892/or. 2021.8156

M Ye, J Ma, B Liu, X Liu, D Ma… - Oncology …, 2019 - spandidos-publications.com
Previous research from our group revealed that the long coding RNA (lncRNA) linc01105 is
associated with neuroblastoma proliferation and apoptosis, and that its expression is …

Expression patterns of immune genes reveal heterogeneous subtypes of high-risk neuroblastoma

Z Liu, CN Grant, L Sun, BA Miller, VS Spiegelman… - Cancers, 2020 - mdpi.com
High risk neuroblastoma (HR-NB) remains difficult to treat, and its overall survival (OS) is still
below 50%. Although HR-NB is a heterogeneous disease, HR-NB patients are currently …

Carbohydrate systems in targeted drug delivery: Expectation and reality

ES Shchegravina, AA Sachkova, SD Usova… - Russian Journal of …, 2021 - Springer
In the end of the twentieth century, the world entered the era of high-tech and personalized
medicine, characterized by the introduction of targeted drugs into clinical practice. Selective …

半乳糖凝集素1 在退变椎间盘中的差异表达

梁卫东, 张树文, 蔡晓宇, 荀传辉, 盛军, 曹锐, 郝宏刚… - 中国组织工程研究, 2023 - cjter.com
摘要背景: 半乳糖凝集素1 调控诸多组织, 器官的生理病理过程, 其与椎间盘退变的关系尚不明确.
目的: 分析半乳糖凝集素1 在不同退变程度椎间盘中的差异性表达, 并探讨其对大鼠椎间盘退变 …

Направленная доставка с применением углеводных систем: ожидания и реальность

ЕС Щегравина, АА Сачкова, СД Усова… - Биоорганическая …, 2021 - elibrary.ru
В конце ХХ века мир вступил в эру высокотехнологичной и персонализированной
медицины, которая характеризуется внедрением в клиническую практику таргетных …

[HTML][HTML] Иммунология и перспективы иммунотерапии злокачественных глиом: использование факторов гуморального иммунитета

СА Кулева, КМ Борокшинова… - Успехи молекулярной …, 2021 - cyberleninka.ru
Глиомы высокой степени злокачественности-агрессивные опухоли центральной
нервной системы. Стандартная химиолучевая терапия данных новообразований не …